Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Cannabis Science Inc

+ Add to Watchlist

CBIS:US

0.0500 USD 0.00000.00%

As of 17:20:00 ET on 03/04/2015.

Snapshot for Cannabis Science Inc (CBIS)

Open: 0.0499 Day's Range: 0.0490 - 0.0505 Volume: 4,213,863
Previous Close: 0.0500 52wk Range: 0.0333 - 0.2055 1-Yr Rtn: -71.43%

Stock Chart for CBIS

No chart data available.
  • CBIS:US 0.0500
  • 1D
  • 1M
  • 1Y
0.0500
Interactive CBIS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CBIS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0100
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 46.09
Shares Outstanding (M) 934.92
30 Day Average Volume 4,240,761
Price/Book (mrq) -
Price/Sale (ttm) 3,552.0192
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CBIS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CBIS

Cannabis Science Inc. is a scientific company involved in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

Dorothy BrayChairmanRaymond C DabneyPres/CEO/Co-Founder
Robert J Kane "Bob"CFO/VP:Investor RelationsChad S JohnsonCOO/Secy/General Counsel
More Company Profile & Key Executives for CBIS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil